Full Text View
Tabular View
No Study Results Posted
Related Studies
Abilify as an Adjunctive Treatment for Refractory Depression.
This study has been completed.
Study NCT00220636   Information provided by St. Luke's-Roosevelt Hospital Center

First Received on September 21, 2005.   Last Updated on June 5, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depressive Disorder, Major
Additional conditions recognized in this trial
Depression
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Abilify (aripiprazole)
Additional drug interventions recognized in this trial
Aripiprazole
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
St. Luke's-Roosevelt Hospital Center
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services